Davide Del Roscio

Dr. Davide Del Roscio

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
FGFrancesco Gentili
Francesco Gentili
IMIlaria Monteleone
Ilaria Monteleone
FMFrancesco Giuseppe Mazzei
Francesco Giuseppe Mazzei
LLLuca Luzzi
Luca Luzzi
DRDavide Del Roscio
Davide Del Roscio
Maria Antonietta MazzeiMaria Antonietta Mazzei
Maria Antonietta Mazzei
Thymic tumors are rare neoplasms even if they are the most common primary neoplasm of the anterior mediastinum. In the era of advanced imaging modalities, such as functional MRI, dual-energy CT, perfusion CT and radiomics, it is possible to improve characterization of thymic epithelial tumors and other mediastinal tumors, assessment of tumor invasion into adjacent structures and detection of secondary lymph nodes and metastases. This review aims to illustrate the actual state of the art in diagnostic imaging of thymic lesions, describing imaging findings of thymoma and differential diagnosis.

SGSusanna Guerrini
Susanna Guerrini
DRDavide Del Roscio
Davide Del Roscio
MZMatteo Zanoni
Matteo Zanoni
PCPaolo Cameli
Paolo Cameli
Elena BargagliElena Bargagli
Elena Bargagli
LLLuca Luzzi
Luca Luzzi
Background: Lung cancer (LC) represents the main cause of cancer-related deaths worldwide, especially because the majority of patients present with an advanced stage of the disease at the time of diagnosis. This systematic review describes the evidence behind screening results and the current guidelines available to manage lung nodules. Methods: This review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The following electronic databases were searched: PubMed, EMBASE, and the Web of Science. Results: Five studies were included in the systematic review. The study cohort included 46,364 patients, and, in this case series, LC was detected in 9028 patients. Among the patients with detected LC, 1261 died of lung cancer, 3153 died of other types of cancers and 4614 died of other causes. Conclusions: This systematic review validates the use of CT in LC screening follow-ups, and bids for future integration and implementation of nodule management protocols to improve LC screening, avoid missed cancers and to reduce the number of unnecessary investigations.